Search for: "Pharmaceuticals USA, Inc." Results 181 - 200 of 917
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Dec 2017, 10:00 am by Gregory B. Williams
December 19, 2017) (consolidated), the Court denied the Motion for Judgment on the Pleadings of defendants Macleods Pharmaceuticals, Ltd. and Macleods Pharma USA, Inc. [read post]
26 Sep 2022, 7:59 pm by Cynthia Marcotte Stamer
The Equal Employment Opportunity Commission (“EEOC”) is suing pharmaceutical giant Lilly USA, LLC, for nationwide age discrimination by intentionally not hiring older workers for pharmaceutical sales representative positions based on their age from April 2017 to 2021. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
19 Sep 2007, 9:54 pm
 The Defendant's named in The USA et al Relator v McKesson et al  include McKesson, Cardinal Health, Amerisourcebergen and Henry Schein, Inc. [read post]
26 Jun 2014, 7:18 pm by Maureen Johnston
The petition of the day is: Teva Pharmaceuticals USA, Inc. v. [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
18 Dec 2014, 11:56 am
Supreme Court invitation brief in generic prescription drug failure to update warning label case initiated in California state court: You can access the CVSG brief filed today in Teva Pharmaceuticals USA, Inc. v. [read post]
11 Apr 2018, 7:17 pm by Aurora Barnes
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
18 Nov 2007, 5:57 pm
Teva Pharmaceuticals USA, Inc. et al. 2:07-cv-05489; filed November 14, 2007 in the... [read post]
26 Aug 2018, 4:35 am by Steve Brachmann
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
20 Jul 2017, 12:47 pm by George L. Kanabe
  On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
20 Feb 2014, 3:37 pm by Lawrence B. Ebert
ZydusZydus Pharmaceuticals USA, Inc. and Cadila Healthcare Limited (“appellants” or “Zydus”) appeal from a final judgment of the U.S. [read post]
27 Apr 2015, 1:28 pm
Supreme Court on Monday rejected Teva Pharmaceuticals USA Inc.'s request to review a Pennsylvania appellate ruling that federal law did not preempt the product liability claims of thousands of generic Reglan users. [read post]
20 Jul 2017, 12:47 pm by George L. Kanabe
  On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
1 May 2017, 12:44 pm by Gene Quinn
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel of Judges Dyk, Mayer and O’Malley determined: “after the AIA, if the […] The post CAFC Interprets AIA On-Sale Bar: Invention details need not be public for sale to be invalidating appeared first on... [read post]
8 Dec 2013, 8:02 pm by Patent Docs
• Defendants: Aurobindo Pharma Ltd.; Aurobindo Pharma USA Inc. [read post]
9 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- Next week, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]